Corient Private Wealth LP Acquires New Stake in Healthpeak Properties, Inc. $DOC

Key Points

• Corient Private Wealth LP acquired 100,234 shares of Healthpeak Properties during the second quarter, valued at approximately $2.15 million. Institutional investors collectively own 93.57% of the REIT’s outstanding stock.
• Healthpeak reported quarterly EPS of $0.08, beating the $0.03 consensus estimate, while revenue rose 11.1% year over year to $771.58 million. The company issued fiscal 2026 EPS guidance of $1.73–$1.77.
• The company declared a monthly dividend of $0.1017 per share, representing a stated 5.8% annualized yield. Analysts maintain a consensus “Hold” rating, with an average price target of $21.72.

Corient Private Wealth LP acquired a new stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 100,234 shares of the real estate investment trust's stock, valued at approximately $2,145,000.

Other large investors also recently bought and sold shares of the company. Advocate Investing Services LLC acquired a new position in shares of Healthpeak Properties during the fourth quarter worth about $26,000. Clearstead Trust LLC lifted its position in Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock valued at $29,000 after purchasing an additional 543 shares during the period. Elyxium Wealth LLC acquired a new stake in Healthpeak Properties in the fourth quarter valued at about $31,000. Clearstead Advisors LLC boosted its holdings in Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock valued at $31,000 after purchasing an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new stake in Healthpeak Properties in the 2nd quarter valued at approximately $33,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $21.06 on Thursday. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.95. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The firm's 50-day simple moving average is $21.57 and its 200 day simple moving average is $19.29. The firm has a market capitalization of $14.52 billion, a PE ratio of 60.17, a P/E/G ratio of 2.57 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm's revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities research analysts predict that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.8%. Healthpeak Properties's dividend payout ratio is currently 348.57%.

Analyst Ratings Changes

Several equities analysts have issued reports on DOC shares. Citigroup boosted their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. Weiss Ratings raised Healthpeak Properties from a "hold (c)" rating to a "hold (c+)" rating in a report on Wednesday, August 19th. Morgan Stanley restated an "equal weight" rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Robert W. Baird upped their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a report on Thursday, August 13th. Finally, BMO Capital Markets raised their target price on Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, June 15th. Four equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $21.72.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source